Medicines and Healthcare products Regulatory Agency · October 12, 2026
- Affected product
- Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80
- Category
- Medical device recalls
- Hazard
- Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations.
Check affected Class 2 Medicines : Norgine Pharmaceuticals Limited, Pedmarqsi 80 identifiers →Medicines and Healthcare products Regulatory Agency · October 9, 2026
- Affected product
- Nova Biomedical StatStrip ketone test strips: disruption to blood
- Category
- Medical device recalls
- Hazard
- Nova Biomedical has identified quality issues affecting specified lots of StatStrip ketone test strips. The affected lots have been associated with quality-control (QC) failures and Nova Biomedical has initiated a recall, advising that these lots should not be…
Check affected Nova Biomedical StatStrip ketone test strips: disruption to blood identifiers →Medicines and Healthcare products Regulatory Agency · October 9, 2026
- Affected product
- Field Safety Notices for October 2026
- Category
- Medical device recalls
- Hazard
- Field Safety Notices for October 2026
Check affected Field Safety Notices for October 2026 identifiers →Medicines and Healthcare products Regulatory Agency · October 5, 2026
- Affected product
- Class 3 Medicines : Norgine Limited, MOVICOL Plain 13.7g powder for
- Category
- Medical device recalls
- Hazard
- Norgine Limited is recalling specific batches of product as a precautionary measure due to some units containing the incorrect amounts of active ingredients.
Check affected Class 3 Medicines : Norgine Limited, MOVICOL Plain 13.7g powder for identifiers →Medicines and Healthcare products Regulatory Agency · October 1, 2026
- Affected product
- Class 4 Medicines Defect Notification: Neuraxpharm UK Limited
- Category
- Medical device recalls
- Hazard
- Neuraxpharm UK Limited have informed the MHRA that a review of the approved Patient Information Leaflet (PIL) has identified discrepancies between the current Neuraxpharm product safety information and the corresponding reference product information.
Check affected Class 4 Medicines Defect Notification: Neuraxpharm UK Limited identifiers →Medicines and Healthcare products Regulatory Agency · September 23, 2026
- Affected product
- Class 4 Medicines Defect Notification: B. Braun Melsungen AG
- Category
- Medical device recalls
- Hazard
- B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg powder and solvent for solution for infusion.
Check affected Class 4 Medicines Defect Notification: B. Braun Melsungen AG identifiers →Medicines and Healthcare products Regulatory Agency · September 17, 2026
- Affected product
- Radiofrequency (RF) Safety Considerations for Wireless
- Category
- Medical device recalls
- Hazard
- The MHRA has conducted a review into the use of wireless cardiotocography (CTG) systems that use radiofrequency (RF) telemetry channels. Signal crossover, erroneous CTG traces and signal dropouts have been identified as patient safety risks associated with…
Check affected Radiofrequency (RF) Safety Considerations for Wireless identifiers →Medicines and Healthcare products Regulatory Agency · September 17, 2026
- Affected product
- Class 4 Medicines Defect Notification: Martindale Pharmaceuticals
- Category
- Medical device recalls
- Hazard
- Martindale Pharmaceuticals has informed the MHRA of an error with the linear barcode of some batches of Clobazam 5mg/5mL and 10mg/5mL Oral Suspension 150mL.
Check affected Class 4 Medicines Defect Notification: Martindale Pharmaceuticals identifiers →Medicines and Healthcare products Regulatory Agency · September 16, 2026
- Affected product
- National Patient Safety Alert: Patient hoists and slings (all
- Category
- Medical device recalls
- Hazard
- Fatal and serious harm continues to occur when patients fall from hoists or slings during transfers and repositioning. A review of recent incidents with a fatal outcome and wider surveillance data shows an average of two deaths per year since 2015.
Check affected National Patient Safety Alert: Patient hoists and slings (all identifiers →Medicines and Healthcare products Regulatory Agency · September 2, 2026
- Affected product
- Filters should be used during the administration of Parenteral
- Category
- Medical device recalls
- Hazard
- Administration of parenteral nutrition without a filter has been associated with a number of adverse incidents including an embolism which resulted in a fatal outcome.
Check affected Filters should be used during the administration of Parenteral identifiers →Medicines and Healthcare products Regulatory Agency · August 26, 2026
- Affected product
- Cobalt-chrome modular neck hip replacements: metal-wear effects and
- Category
- Medical device recalls
- Hazard
- An MHRA investigation has found increased risks of wear and corrosion associated with multiple cobalt-chrome (Co-Cr) modular neck hip stem components, including a potential increased occurrence of revision surgery due to adverse local tissue reaction (ALTR).
Check affected Cobalt-chrome modular neck hip replacements: metal-wear effects and identifiers →Medicines and Healthcare products Regulatory Agency · August 24, 2026
- Affected product
- NGPod pH testing device: quarantine and dispose of all devices
- Category
- Medical device recalls
- Hazard
- The NGPod handheld device and NGPod sensor, used to test pH to aid the placement of nasogastric tubes, is being withdrawn from the UK market. The manufacturer has ceased trading in the UK. Users should quarantine all remaining stock and dispose of all NGPod…
Check affected NGPod pH testing device: quarantine and dispose of all devices identifiers →Medicines and Healthcare products Regulatory Agency · August 20, 2026
- Affected product
- Class 2 Medicines : Zentiva Pharma UK Limited, Fingolimod Zentiva
- Category
- Medical device recalls
- Hazard
- Zentiva UK Pharma Limited are recalling one batch of Fingolimod Zentiva 0.5 mg Capsules (BN 4L01372H) as a precautionary measure due to a potential risk of contamination with metal particles.
Check affected Class 2 Medicines : Zentiva Pharma UK Limited, Fingolimod Zentiva identifiers →Medicines and Healthcare products Regulatory Agency · August 18, 2026
- Affected product
- Rectal catheters sold for personal use (gas and colic relievers): Do
- Category
- Baby product recalls, Medical device recalls
- Hazard
- Do not use rectal catheters sold for personal use (gas and colic relievers) in infants, including for colic, gas-related discomfort or constipation. Stop using these products immediately and dispose of any unused devices.
Check affected Rectal catheters sold for personal use (gas and colic relievers): Do identifiers →Medicines and Healthcare products Regulatory Agency · August 17, 2026
- Affected product
- National Patient Safety Alert: ResMed Astral 100 and 150
- Category
- Medical device recalls
- Hazard
- ResMed has issued a Field Safety Notice regarding Astral 100 and 150 ventilators and associated Printed Circuit Board Assembly spare parts manufactured prior to October 2024. A fault in the device can cause unexpected interruption of ventilation therapy.
Check affected National Patient Safety Alert: ResMed Astral 100 and 150 identifiers →Medicines and Healthcare products Regulatory Agency · August 10, 2026
- Affected product
- Devices supplied without valid UKCA/CE conformity markings or
- Category
- Medical device recalls
- Hazard
- The MHRA has become aware of a number of medical devices being supplied on the UK market that do not comply with the requirements of the UK Medical Device Regulations 2002 (UK MDR 2002) or with the EU Medical Devices Regulation (EU) 2017/745 (EU MDR).
Check affected Devices supplied without valid UKCA/CE conformity markings or identifiers →Medicines and Healthcare products Regulatory Agency · August 6, 2026
- Affected product
- Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine
- Category
- Medical device recalls
- Hazard
- The MHRA is providing an update on defects previously identified with Belzer solutions for the preservation of donated organs. This DSI replaces advice in DSI/2023/005.
Check affected Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine identifiers →Medicines and Healthcare products Regulatory Agency · August 4, 2026
- Affected product
- Dräger Atlan Anaesthesia workstations: ventilator failure
- Category
- Medical device recalls
- Hazard
- In April 2026, Dräger issued a follow-up Field Safety Notice expanding the number of Atlan Anaesthesia workstation devices affected by a manufacturing defect that may result in mechanical ventilation failure.
Check affected Dräger Atlan Anaesthesia workstations: ventilator failure identifiers →Medicines and Healthcare products Regulatory Agency · July 23, 2026
- Affected product
- Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby
- Category
- Medical device recalls
- Hazard
- Neuraxpharm UK Ltd has informed the MHRA of missing safety information in the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for certain batches of Tuzulby prolonged release 20mg, 30mg and 40mg chewable tablets.
Check affected Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby identifiers →Medicines and Healthcare products Regulatory Agency · July 20, 2026
- Affected product
- Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd
- Category
- Medical device recalls
- Hazard
- Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in the bottles.
Check affected Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd identifiers →Medicines and Healthcare products Regulatory Agency · July 13, 2026
- Affected product
- Class 2 Medicines : Beckton Dickson UK Ltd, ChloraPrep 1mL
- Category
- Medical device recalls
- Hazard
- Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% w/v / 70% v/v cutaneous solution 1mL applicators due to a potential breach of sterility in the packaging process.
Check affected Class 2 Medicines : Beckton Dickson UK Ltd, ChloraPrep 1mL identifiers →Medicines and Healthcare products Regulatory Agency · July 9, 2026
- Affected product
- Class 2 Medicines : Bristol Laboratories Limited
- Category
- Medical device recalls
- Hazard
- Bristol Laboratories Limited is recalling one batch (7124002) of Phenoxymethylpenicillin 250 mg/5 ml Oral Solution Sugar Free due to product labelling issues.
Check affected Class 2 Medicines : Bristol Laboratories Limited identifiers →Medicines and Healthcare products Regulatory Agency · June 30, 2026
- Affected product
- Class 3 Medicines : Flamingo Pharma UK Ltd, Flucloxacillin Capsules
- Category
- Medical device recalls
- Hazard
- Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL for Flucloxacillin BP 500mg Capsules.
Check affected Class 3 Medicines : Flamingo Pharma UK Ltd, Flucloxacillin Capsules identifiers →Medicines and Healthcare products Regulatory Agency · June 30, 2026
- Affected product
- UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited
- Category
- Medical device recalls
- Hazard
- Relonchem Limited have informed the MHRA that particles have been observed inside some bottles of Gabapentin Relonchem Oral Solution, identified through a customer complaint.
Check affected UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited identifiers →Medicines and Healthcare products Regulatory Agency · June 29, 2026
- Affected product
- Class 4 Medicines Defect Notification: Brancaster Pharma Limited
- Category
- Medical device recalls
- Hazard
- Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were released with an outdated PIL.
Check affected Class 4 Medicines Defect Notification: Brancaster Pharma Limited identifiers →Medicines and Healthcare products Regulatory Agency · June 16, 2026
- Affected product
- Class 3 Medicines : Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml
- Category
- Medical device recalls
- Hazard
- Orbit Pharma Limited is recalling a specific batch of Cyclizine Lactate 50 mg/ml Solution for injection as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies identified at the manufacturing site.
Check affected Class 3 Medicines : Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml identifiers →Medicines and Healthcare products Regulatory Agency · June 8, 2026
- Affected product
- Class 4 Medicines Defect Notification: Cadila Pharmaceuticals
- Category
- Medical device recalls
- Hazard
- Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.
Check affected Class 4 Medicines Defect Notification: Cadila Pharmaceuticals identifiers →Medicines and Healthcare products Regulatory Agency · June 4, 2026
- Affected product
- Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi
- Category
- Medical device recalls
- Hazard
- Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to the skin” when the product is licensed for subcutaneous use.
Check affected Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi identifiers →Medicines and Healthcare products Regulatory Agency · June 2, 2026
- Affected product
- Class 2 Medicines : Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and
- Category
- Medical device recalls
- Hazard
- Becton Dickinson UK Ltd are recalling batches of ChloraPrep 2% 1mL applicators and ChloraPrep Frepp 2% 1.5 mL applicators due to a potential breach of sterility in the packaging process.
Check affected Class 2 Medicines : Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and identifiers →Medicines and Healthcare products Regulatory Agency · May 28, 2026
- Affected product
- Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg
- Category
- Medical device recalls
- Hazard
- Crescent Pharma Limited is initiating a precautionary recall of one batch of Ramipril 2.5 mg Capsules following the identification of a potential packaging error at the manufacturing site.
Check affected Class 2 Medicines : Crescent Pharma Limited, Ramipril 2.5 mg identifiers →Medicines and Healthcare products Regulatory Agency · May 27, 2026
- Affected product
- Allurion Gastric Balloon: Updated safety information the risks of
- Category
- Medical device recalls
- Hazard
- In rare instances, the Allurion Gastric Balloon has not transited through the stomach or bowel as intended, leading to complications such as gastric outlet obstruction, small bowel obstruction and gastric perforation.
Check affected Allurion Gastric Balloon: Updated safety information the risks of identifiers →Medicines and Healthcare products Regulatory Agency · May 20, 2026
- Affected product
- severe harm from use of incorrect giving (administration) set for
- Category
- Medical device recalls
- Hazard
- There is a potential for serious harm to patients if an intravenous (IV) infusion giving set is used instead of a blood transfusion giving set to deliver a transfusion of blood or blood components.
Check affected severe harm from use of incorrect giving (administration) set for identifiers →Medicines and Healthcare products Regulatory Agency · May 19, 2026
- Affected product
- Kimal Procedure Packs containing recalled components: Namic
- Category
- Medical device recalls
- Hazard
- Medline Industries LP and Kimal PLC have identified safety issues with the Namic Angiographic Control Syringes with RA and Namic White Star Off Handle Manifold devices, and have issued field safety notices to affected UK hospitals advising that they should not…
Check affected Kimal Procedure Packs containing recalled components: Namic identifiers →Medicines and Healthcare products Regulatory Agency · May 14, 2026
- Affected product
- Class 4 Medicines Defect Notification: Fresenius Medical Care
- Category
- Medical device recalls
- Hazard
- Fresenius Medical Care Deutschland GmbH have identified an error in the Braille printed on the outer label.
Check affected Class 4 Medicines Defect Notification: Fresenius Medical Care identifiers →Medicines and Healthcare products Regulatory Agency · May 11, 2026
- Affected product
- Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide
- Category
- Medical device recalls
- Hazard
- Milpharm Limited has identified a discrepancy in the Patient Information Leaflet (PIL) approved for Loperamide hydrochloride 2 mg Orodispersible Tablets.
Check affected Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide identifiers →Medicines and Healthcare products Regulatory Agency · April 28, 2026
- Affected product
- Class 2 Medicines : Amarox Limited, Sertraline 100mg film-coated
- Category
- Medical device recalls
- Hazard
- of more pronounced serotonergic effects. The risk is however higher in patients with pre-existing cardiac conditions, those aged over 65 years, or those taking concomitant serotonergic or QT prolonging medication. Additionally, as some patients may require…
Check affected Class 2 Medicines : Amarox Limited, Sertraline 100mg film-coated identifiers →Medicines and Healthcare products Regulatory Agency · April 23, 2026
- Affected product
- Class 3 Medicines : Omega Pharma Ltd, Napralief 250mg
- Category
- Medical device recalls
- Hazard
- with this page
Check affected Class 3 Medicines : Omega Pharma Ltd, Napralief 250mg identifiers →Medicines and Healthcare products Regulatory Agency · April 22, 2026
- Affected product
- Class 4 Medicines Defect Notification: Doncaster Pharma Limited
- Category
- Medical device recalls
- Hazard
- of dosing errors arising from the Braille issue. Advice for Patients: No action is needed from patients, continue to take medication from these batches of tablets. The actions will be controlled by the healthcare professionals who prescribe or dispense the…
Check affected Class 4 Medicines Defect Notification: Doncaster Pharma Limited identifiers →Medicines and Healthcare products Regulatory Agency · April 20, 2026
- Affected product
- Class 2 Medicines : Crescent Pharma Limited, Ramipril 10mg capsules
- Category
- Medical device recalls
- Hazard
- with this page
Check affected Class 2 Medicines : Crescent Pharma Limited, Ramipril 10mg capsules identifiers →
